.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
VET CBD is stocked at 386 licensed dispensaries across California, Arizona, and Minnesota, 373 of them in California, with the deepest coverage in Los Angeles, Sacramento, Long Beach, San Diego, and Santa Ana. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
VET CBD concentrated 95.09% of July 2026 sales in Tincture & Sublingual, where category sales fell 2.93% year over year but rose 24.46% month over month, while the smaller Edible line held 4.91% share with a 15.66% year-over-year decline and a 72.15% month-over-month spike. Across the brand, sales declined 3.64% year over year and the average price decreased 1.22% to $42.49, yet within Tincture & Sublingual the average price sat higher at $45.40, implying mix- and price-tier effects. This pattern implies the July 2026 rebound was driven primarily by a month-over-month surge in Tincture & Sublingual while Edibles provided incremental lift off a smaller base, and concentration risk remains high given a 24-month sales change of -1.06% alongside a rank of 3 in Tincture & Sublingual in California.
The 95.09% reliance on Tincture & Sublingual, paired with a rank of 3 in California, positions VET CBD as a category specialist whose month-over-month acceleration of 24.46% in that segment can drive quick swings in total performance, while the 72.15% month-over-month rise in Edibles offers optionality without yet diversifying risk meaningfully. With Tincture & Sublingual down 2.93% year over year and Edibles down 15.66% year over year, the mix skews toward segments with contracting annual comps, so maintaining the price premium in Tincture & Sublingual ($45.40 vs. the brand’s $42.49 average) becomes the practical lever for sustaining rank 3 positioning and offsetting the brand’s 3.64% year-over-year sales decline.
Competitive Landscape
VET CBD sits at rank #3 in California Tincture & Sublingual in July 2026, improving 1 position YoY from #4 and rising 1 position since April 2026 from #4, while peak rank matches current at #3 in July 2026; in comparison, Yummi Karma climbed from #2 to #1 with a 15.99% YoY sales increase, and Papa & Barkley slipped from #1 to #2 with a -13.54% YoY sales change. Against the chasing pack, Care By Design moved from #3 to #4 alongside a -13.46% YoY sales change, while ABX / AbsoluteXtracts advanced from #7 to #5 with a 30.19% YoY sales increase, indicating VET CBD’s upward nudge is occurring amid faster gainers both above and below. The pattern implies VET CBD’s incremental rank gains are vulnerable without a step-change in velocity, as rising leaders are adding double-digit percentages while the nearest pursuer advances two ranks in a year.
Notable Products
CBD/THC 10:1 Extra Strength Tincture (250mg CBD, 25mg THC, 60ml, 2oz) posted the steepest decline at -16.0% month over month and slid to rank 9, while CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml) climbed 42.1% to rank 1. Two other 20:1 tinctures moved up together, with the 1000mg CBD, 50mg THC format rising 30.4% at rank 6 and the 250mg CBD, 12.5mg THC format up 17.0% at rank 2, and four of the top five SKUs are Tincture & Sublingual. The CBD Calming Peanut Butter Soft Chews 60-Pack (300mg CBD) gained 40.7% at rank 8 while the 30-Pack rose 27.8% at rank 7, but combined Edible momentum still trails the 20:1 tincture cluster where the 500mg CBD, 25mg THC format advanced 15.9% at rank 4. This pattern implies a portfolio tilt toward higher-ratio 20:1 tinctures as the commercial anchor, with Edibles serving as an expanding but secondary attachment that benefits from the tincture-led traffic.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
